The same brain cells linked to disorientation in Alzheimer's disease have been preserved—and even slightly increased—across ...
Novartis today announced that the US Food and Drug Administration (FDA) has approved Itvisma® (onasemnogene abeparvovec-brve) for the treatment of children two years and older, teens, and adults ...
ITVISMA is a prescription gene therapy used to treat adults and children 2 years of age and older with spinal muscular atrophy (SMA). ITVISMA is given as a one-time intrathecal injection. What is the ...
A FREE NHS jab could be the most promising drug yet to stop Alzheimer’s, experts say. Two other medicines, to treat erectile dysfunction and motor neurone disease, also showed strong potential.
New research commissioned by Challenge Works and undertaken by the Office of Health Economics (OHE) estimates that a ...
Unique conditions in space could allow for experiments and breakthroughs in the search for cures to some of the Earth’s most ...
Scientists have identified a new drug that safeguards nerve cells harmed by 'one of the cruellest diseases', providing hope for substantially slowing its progress. Preliminary studies with M102 showed ...
Alzheimer's is a devastating disease that results in memory loss and cognitive decline. It's caused by brain cells dying and the brain itself shrinking from a buildup of proteins. Millions of seniors ...
(MEMPHIS, Tenn. – October 29, 2025) Motor neuron diseases, such as amyotrophic lateral sclerosis (ALS) and hereditary spastic paraplegia (HSP), share physical similarities but have been largely viewed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback